These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21410249)

  • 21. Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.
    Hussain J; Rea C
    J Chem Inf Model; 2010 Mar; 50(3):339-48. PubMed ID: 20121045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graphs and networks in chemical and biological informatics: past, present and future.
    Sukumar N; Krein MP
    Future Med Chem; 2012 Oct; 4(16):2039-47. PubMed ID: 23157237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated decision support for assessing chemical liabilities.
    Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
    J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quo vadis, virtual screening? A comprehensive survey of prospective applications.
    Ripphausen P; Nisius B; Peltason L; Bajorath J
    J Med Chem; 2010 Dec; 53(24):8461-7. PubMed ID: 20929257
    [No Abstract]   [Full Text] [Related]  

  • 25. Off-target networks derived from ligand set similarity.
    Keiser MJ; Hert J
    Methods Mol Biol; 2009; 575():195-205. PubMed ID: 19727616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery.
    Tintori C; Corradi V; Magnani M; Manetti F; Botta M
    J Chem Inf Model; 2008 Nov; 48(11):2166-79. PubMed ID: 18942779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactivity landscape modeling: chemoinformatic characterization of structure-activity relationships of compounds tested across multiple targets.
    Waddell J; Medina-Franco JL
    Bioorg Med Chem; 2012 Sep; 20(18):5443-52. PubMed ID: 22178187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
    Duffy BC; Zhu L; Decornez H; Kitchen DB
    Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarity metrics for ligands reflecting the similarity of the target proteins.
    Schuffenhauer A; Floersheim P; Acklin P; Jacoby E
    J Chem Inf Comput Sci; 2003; 43(2):391-405. PubMed ID: 12653501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Template CoMFA: the 3D-QSAR Grail?
    Cramer RD; Wendt B
    J Chem Inf Model; 2014 Feb; 54(2):660-71. PubMed ID: 24437630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs.
    Perola E
    J Med Chem; 2010 Apr; 53(7):2986-97. PubMed ID: 20235539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current trends in antimicrobial agent research: chemo- and bioinformatics approaches.
    Hammami R; Fliss I
    Drug Discov Today; 2010 Jul; 15(13-14):540-6. PubMed ID: 20546918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SERAPhiC: a benchmark for in silico fragment-based drug design.
    Favia AD; Bottegoni G; Nobeli I; Bisignano P; Cavalli A
    J Chem Inf Model; 2011 Nov; 51(11):2882-96. PubMed ID: 21936510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoinformatics-applications in food chemistry.
    Martinez-Mayorga K; Medina-Franco JL
    Adv Food Nutr Res; 2009; 58():33-56. PubMed ID: 19878857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of multitarget activity ridges in high-dimensional bioactivity spaces.
    Gupta-Ostermann D; Bajorath J
    J Chem Inf Model; 2012 Oct; 52(10):2579-86. PubMed ID: 23004919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.